Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 8 Breast Neoplasms 8 Neoplasms 7 Depression 6 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Anxiety Disorders 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Prostatic Hyperplasia 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell, Marginal Zone 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Fatigue 2

Interventions

Temozolomide 42 Magnetic Resonance Spectroscopy 41 Radiotherapy 22 Specimen Handling 18 Biopsy 13 X-Rays 10 Radiation 10 trametinib 8 Bevacizumab 8 Nivolumab 7 Blood Specimen Collection 7 olaparib 6 fluorodopa F 18 6 dabrafenib 6 Radiotherapy, Intensity-Modulated 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 Lomustine 6 pembrolizumab 5 abemaciclib 5 Standard of Care 5 vorasidenib 4 ulixertinib 4 larotrectinib 4 ivosidenib 4 erdafitinib 4 Surgical Procedures, Operative 4 Dianhydrogalactitol 4 Cyclophosphamide 4 Aminolevulinic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Therapeutics × 1 year × Clear all

NCT05406700 2026-02-09

Niraparib In Recurrent IDH 1/2 Gliomas

Massachusetts General Hospital

Phase EARLY_PHASE1 Active not recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡